Injection pens for the weight-loss treatment Wegovy, manufactured by Novo Nordisk A/S, on display during a news conference in Mumbai, India, on Tuesday, June 24, 2025. Novo Nordisk said it will sell its blockbuster weight-loss treatment Wegovy in India starting at $50 a week, tailoring the price to match the pocket of consumers in a nation with the world’s third-largest obese population.

Send this story to anyone — or drop the embed into a blog post, Substack, Notion page. Every play sends rev-share back to Bloomberg · Markets.

𝕏 Post on X in Share on LinkedIn ✉ Email a friend

Heard via Storyflo

Get audio versions of every article you read.

Pick what matters — your audio curator gets you into your daily flo.

Join the listener waitlist